<PAGE>
PROSPECTUS SUPPLEMENT DATED OCTOBER 17, 2000
(TO PROSPECTUS DATED April 28, 2000)
Filed Pursuant to
Rule 424(b)(3)
Commission File No. 333-33872
416,667 SHARES
(CELL THERAPEUTICS LOGO)
COMMON STOCK
This Prospectus Supplement supplements the Prospectus dated April 28, 2000
(the "Prospectus) of Cell Therapeutics, Inc. ("cti" or the "Company") relating
to the sale by certain shareholders of the Company or by pledgees, donees,
transferees or other successors in interest that receive such shares as a gift,
partnership distribution or other non-sale related transfer (the "Selling
Shareholders") of up to 416,667 shares of cti's Common Stock, no par value (the
"Common Stock"), who received such shares in connection with the private
placement of the Company's stock in February 2000. This Prospectus Supplement
should be read in conjunction with the Prospectus, and this Prospectus
Supplement is qualified by reference to the Prospectus except to the extent that
information herein contained supersedes the information contained in the
Prospectus. Capitalized terms used in this Prospectus Supplement and not
otherwise defined herein have the meanings specified in the Prospectus.
SELLING SHAREHOLDER
Recently ProQuest Investments, L.P. and ProQuest Companion Fund, L.P.
(collectively, "ProQuest") distributed 416,667 shares of cti Common Stock to
various limited and general partners, which distributees were not specifically
named in the Prospectus. ProQuest Investments, L.P. distributed 411,333 shares
of cti Common Stock and ProQuest Companion Fund, L.P. distributed 5,334 shares
of cti Common Stock. The following table provides certain information with
respect to the number of shares of Common Stock beneficially owned by
shareholders of the Company who were not specifically identified in the
Prospectus as a Selling Shareholder, the percentage of outstanding shares of
Common Stock of the Company this represents and the number of shares of Common
Stock to be registered for sale hereby. The table of Selling Shareholders in
the Prospectus is hereby amended to include certain limited and general partners
of ProQuest as Selling Shareholders.
<PAGE>
<TABLE>
<CAPTION>
Number of Shares Percent of Number of Shares
Beneficially Outstanding Registered for Sale
Name of Beneficial Owner Owned(1) Shares Hereby
------------------------ ---------------- ----------- -------------------
<S> <C> <C> <C>
Howard Berkowitz (2) 3,788 * 3,788
Cindy S. Butler, Trustee, Vadasz 3,788 * 3,788
Investment Trust dated 3/15/1999 (2)
Jeremiah Callaghan & Karen 3,788 * 3,788
Callaghan (2)
Paul F. Glenn, as Trustee of the Paul 3,788 * 3,788
F. Glenn Revocable Trust dated
August 22, 1990 (2)
ALZA Corporation (2) 75,756 * 75,756
CIBC Oppenheimer as Custodian for 3,788 * 3,788
David A. Ederer - IRA (2)
Milken Family Foundation (2) 9,470 * 9,470
PACO (2) 18,939 * 18,939
L&S Milken Foundation (2) 3,788 * 3,788
BancBoston Investments Inc. (2) 7,576 * 7,576
The Andrew S. Grove & Eva Kastan 4,200 * 4,200
Grove Living Trust dated 6/4/1970 (4)
Leon D. Black 1997 Four Year Trust (2) 3,788 * 3,788
Elsa D. Prince Living Trust dated 3,788 * 3,788
1/27/1976 (2)
WRS Advisors III, L.L.C. (2) 1,894 * 1,894
OWC Partnership (2) 7,576 * 7,576
Sidney Kimmel (2) 3,788 * 3,788
</TABLE>
-2-
<PAGE>
<TABLE>
<CAPTION>
Number of Shares Percent of Number of Shares
Beneficially Outstanding Registered for Sale
Name of Beneficial Owner Owned(1) Shares Hereby
------------------------ ---------------- ----------- -------------------
<S> <C> <C> <C>
Howard Lester (2) 7,576 * 7,576
GVI Holdings, Inc. (2) 3,788 * 3,788
Earle I. Mack (2) 1,894 * 1,894
Avram Miller Trustee, The Avram 1,894 * 1,894
Miller Trust dated 11/22/1995 (2)
American Bible Society (2) 9,470 * 9,470
Frog Partners II, L.L.C. (2) 1,894 * 1,894
National City Bank, Trustee for the 7,576 * 7,576
Brown-Forman Corporation Retirement
Trust (2)
Sofinov Societe Financiere 75,756 * 75,756
D'Innovation (2)
Gene A. Salmon D/B/A G-S Service 3,788 * 3,788
Co. (2)
William A. Schwartz (2) 3,788 * 3,788
Merv Adelson, Trustee, the Merv 3,788 * 3,788
Adelson Trust dated 9/29/1992 (2)
The Hodson Trust dated 2/17/1920 (2) 18,939 * 18,939
Jerome S. Moss (2) 3,788 * 3,788
ANDA-Proquest, L.L.C. (2) 56,817 * 56,817
Stephen C. Swid (2) 3,788 * 3,788
Michael L. Tarnopol (2) 3,788 * 3,788
David H. Koch (2) 7,576 * 7,576
Lloyd K. Benson (3) 103 * 103
James C. Blair (3) 412 * 412
R. Scott Greer (3) 186 * 186
Leroy Hood, M.D., Ph.D. (3) 926 * 926
</TABLE>
-3-
<PAGE>
<TABLE>
<CAPTION>
Number of Shares Percent of Number of Shares
Beneficially Outstanding Registered for Sale
Name of Beneficial Owner Owned(1) Shares Hereby
------------------------ ---------------- ----------- -------------------
<S> <C> <C> <C>
Zola P. Horovitz (3) 103 * 103
Yasunori Kaneko, Trustee, Kaneko 412 * 412
Family Trust dated 1/20/1992 (3)
David R. King and Eunice S. King, as 206 * 206
tenants by the entireties (3)
Mark & Becky Levin (3) 412 * 412
J. Misha Petkevich, Trustee, 111 * 111
Petkevich Family Trust dated
5/2/1996 (3)
Thomas H. Robinson (3) 412 * 412
Peter T. Scardino (3) 247 * 247
Howard Scher (3) 206 * 206
Mark J. Simon (3) 309 * 309
Nicholas J. Simon III (3) 412 * 412
Jonathan Simons M.D. (3) 103 * 103
Steven D. Singer (3) 206 * 206
Leon G. Smith (3) 103 * 103
Jay Moorin (5) 14,195 * 14,195
Jeremy Goldberg (5) 14,195 * 14,195
Alain Schreiber (5) 2,734 * 2,734
Domain Associates, L.L.C. (5) 3,638 * 3,638
Pasquale DeAngelis (5) 406 * 406
Joyce Tsang (5) 406 * 406
Stuart Holden (5) 813 * 813
</TABLE>
______________________
* Represents beneficial ownership of less than 1%.
-4-
<PAGE>
(1) The registration statement to which the Prospectus and this Prospectus
Supplement relate shall also cover any additional shares of Common Stock
which become issuable in connection with the Shares registered for sale
hereby by reason of any stock dividend, stock split, recapitalization or
other similar transaction effected without the receipt of consideration
which results in an increase in the number of the Company's outstanding
shares of Common Stock.
(2) Such Selling Shareholder is a Limited Partner in ProQuest Investments, L.P.
(3) Such Selling Shareholder is a Limited Partner in ProQuest Companion Fund,
L.P.
(4) Such Selling Shareholder is a Limited Partner in ProQuest Investments, L.P.
and ProQuest Companion Fund, L.P.
(5) Such Selling Shareholder is a Member of the General Partner of ProQuest
Investments, L.P. and ProQuest Companion Fund, L.P.
-5-
